MedPath

University of Manitoba

University of Manitoba logo
🇨🇦Canada
Ownership
Private
Established
1877-02-28
Employees
5K
Market Cap
-
Website
http://www.umanitoba.ca

Outcome and Treatment of Complex Sleep Apnea

Phase 2
Withdrawn
Conditions
Sleep Apnea
Interventions
Device: Non-invasive positive pressure ventilator
First Posted Date
2010-06-04
Last Posted Date
2015-02-13
Lead Sponsor
University of Manitoba
Registration Number
NCT01137214
Locations
🇨🇦

Miseracordia Sleep Disorders Centre, Winnipeg, Manitoba, Canada

Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols

Phase 4
Completed
Conditions
Hyperlipidemia
Interventions
Dietary Supplement: Plant sterol
Dietary Supplement: Placebo
First Posted Date
2010-05-27
Last Posted Date
2017-05-09
Lead Sponsor
University of Manitoba
Target Recruit Count
71
Registration Number
NCT01131832
Locations
🇺🇸

USDA-ARS, Beltsville Human Nutrition Research Center, Beltsville, Maryland, United States

🇨🇦

Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba, Winnipeg, Manitoba, Canada

The Efficacy and Cost Effectiveness of Preoperative and Postoperative Cryotherapy in Proximal Tibia Fractures

Phase 3
Terminated
Conditions
Proximal Tibia Fracture
Interventions
Device: Room temperature cuff
Device: Cryotherapy
First Posted Date
2010-04-16
Last Posted Date
2017-05-08
Lead Sponsor
University of Manitoba
Target Recruit Count
20
Registration Number
NCT01104831
Locations
🇨🇦

Winnipeg Health Sciences Centre, Winnipeg, Manitoba, Canada

Cholesterol Metabolism in Heterozygous Phytosterolemia

Phase 1
Completed
Conditions
Cardiovascular Disease
Interventions
Dietary Supplement: phytosterol ester
First Posted Date
2010-04-13
Last Posted Date
2011-05-02
Lead Sponsor
University of Manitoba
Target Recruit Count
26
Registration Number
NCT01102647
Locations
🇨🇦

University of Manitoba, Winnipeg, Manitoba, Canada

Efficacy and Safety of Titrated Oral Misoprostol Solution for Labor Induction at Term

Not Applicable
Completed
Conditions
Labor Induction at Term
First Posted Date
2010-02-18
Last Posted Date
2013-12-10
Lead Sponsor
University of Manitoba
Target Recruit Count
250
Registration Number
NCT01070472
Locations
🇨🇦

St. Boniface General Hospital, Winnipeg, Manitoba, Canada

Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males

Phase 4
Completed
Conditions
Hypotension
Spinal Cord Injury
Interventions
Drug: placebo
First Posted Date
2010-02-11
Last Posted Date
2015-07-17
Lead Sponsor
University of Manitoba
Target Recruit Count
20
Registration Number
NCT01067391
Locations
🇨🇦

Health Sciences Centre Rehabilitation Hospital, Winnipeg, Manitoba, Canada

CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity

Phase 2
Completed
Conditions
Apnea of Prematurity
Interventions
Other: CO2 inhalation
First Posted Date
2010-02-10
Last Posted Date
2010-03-03
Lead Sponsor
University of Manitoba
Target Recruit Count
87
Registration Number
NCT01066728
Locations
🇨🇦

Health Sciences Centre, Winnipeg, Manitoba, Canada

🇨🇦

St Boniface General Hospital, Winnipeg, Manitoba, Canada

Pulmonary Function Changes and Diaphragmatic Paralysis Following Ultrasound Guided Supraclavicular Brachial Plexus Blockade: The Effects of Decreased Local Anesthetic Volume

Completed
Conditions
Lung Function
Diaphragmatic Function
Interventions
Procedure: Supraclavicular Block
First Posted Date
2010-01-13
Last Posted Date
2017-05-08
Lead Sponsor
University of Manitoba
Target Recruit Count
30
Registration Number
NCT01048021
Locations
🇨🇦

HSC Pain Management Centre, Winnipeg, Manitoba, Canada

Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans

Phase 1
Completed
Conditions
Body Weight
Body Composition
Hyperlipidemia
Inflammation
Oxidative Stress
Interventions
Dietary Supplement: Safflower oil
Dietary Supplement: Clarinol G-80 ® treatment
Dietary Supplement: G-c9, t11
First Posted Date
2010-01-12
Last Posted Date
2010-01-12
Lead Sponsor
University of Manitoba
Target Recruit Count
36
Registration Number
NCT01047280

Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis

Phase 1
Completed
Conditions
Psoriasis
Interventions
Dietary Supplement: Golden brown algae
Dietary Supplement: Corn starch
Dietary Supplement: Unique Marine Algae Concentrate (UMAC)
First Posted Date
2010-01-11
Last Posted Date
2011-03-16
Lead Sponsor
University of Manitoba
Target Recruit Count
30
Registration Number
NCT01045395
Locations
🇨🇦

Ricahrson Centre for Functionl Foods and Nutraceuticals, U of M, Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath